Evidence map›Paper›PMID 38069124›Full record

ArticleInternational journal of molecular sciences2023

Alteration in Melanin Content in Retinal Pigment Epithelial Cells upon Hydroquinone Exposure.

Takeyuki Nishiyama, Hiroki Tsujinaka, Tetsuo Ueda, Nahoko Ogata

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Takeyuki NishiyamaDepartment of Ophthalmology, Nara Medical University, Kashihara 634-8521, Japan.
Hiroki TsujinakaDepartment of Ophthalmology, Nara Medical University, Kashihara 634-8521, Japan.
Tetsuo UedaDepartment of Ophthalmology, Nara Medical University, Kashihara 634-8521, Japan.
Nahoko OgataDepartment of Ophthalmology, Nara Medical University, Kashihara 634-8521, Japan.
Nara Medical University · JP

Funding

JSPS KAKENHI 20K18389
6 · The paper itself

Abstract

Abnormal pigmentation or depigmentation of the retinal pigment epithelium (RPE) is a precursor to neovascular age-related macular degeneration (nAMD). In this study, we evaluated the effects of hydroquinone (HQ), the most potent reductant in cigarette smoke, on the melanin production in RPE cells. Induced pluripotent stem cell (iPS)-derived RPE and adult retinal pigment epithelial (ARPE-19) cells were cultured with HQ. Real-time reverse transcription polymerase chain reaction revealed that the expression of melanin-related genes decreased due to the addition of HQ for 1 day. Enzyme-linked immunosorbent immunoassay showed that the concentration of melanin significantly decreased due to the addition of HQ for 24 h. A suspension of RPE cells with HQ for 24 h was prepared, and the absorbance was measured. The absorbance decreased particularly under blue light, suggesting that blue light may reach the choroid and cause choroidal inflammation. Additionally, melanin levels significantly decreased due to the addition of HQ for 1 week. After blue light irradiation on the RPE with HQ for 1 week, the vascular endothelial growth factor in the medium was significantly higher in the HQ group than in the control group. HQ-induced changes in melanin production may be responsible for the uneven pigmentation of the RPE, and these changes may cause nAMD.

Indexed as

HydroquinonesMelaninsEpithelial CellsRetinal Pigment EpitheliumVascular Endothelial Growth Factor AhydroquinoneHydroquinonesMelaninsVascular Endothelial Growth Factor Ablue lighthydroquinonemelanin productionneovascular age-related macular degenerationvascular endothelial growth factor

Identifiers

PMID38069124
PMCPMC10706107
OpenAlexW4389056716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.